Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:19 AM
Ignite Modification Date:
2025-12-25 @ 2:19 AM
NCT ID:
NCT00210834
Eligibility Criteria:
Inclusion Criteria:
* Histologically confirmed diagnosis of non-myeloid malignancy
* Baseline hemoglobin value of \<= 11 g/dL unrelated to transfusion
* Planned chemotherapy for a minimum of 12 weeks during the study
* Life expectancy of \>= 6 months
* ECOG Performance Status 0-2
Exclusion Criteria:
* Diagnosis of a myeloid malignancy or known history of myelodysplasia
* Planned non-palliative radiation during the study
* Anemia due to factors other than cancer/chemotherapy
* Prior treatment with Epoetin alfa or any other erythropoietic agent within the previous three months
* History of uncontrolled cardiac arrhythmias or history of pulmonary emboli, deep vein thrombosis, ischemic stroke, other arterial or venous thrombotic events (excluding superficial thromboses), or known history of chronic coagulation disorder
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00210834
Study Brief:
Protocol Section:
NCT00210834